Harvard Bioscience Revenue 2012-2026 | HBIO
Harvard Bioscience revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Harvard Bioscience Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $87 |
| 2024 | $94 |
| 2023 | $112 |
| 2022 | $113 |
| 2021 | $119 |
| 2020 | $102 |
| 2019 | $116 |
| 2018 | $121 |
| 2017 | $77 |
| 2016 | $105 |
| 2015 | $109 |
| 2014 | $109 |
| 2013 | $105 |
| 2012 | $111 |
| 2011 | $109 |
|
Harvard Bioscience Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-03-31 | $21 |
| 2025-12-31 | $24 |
| 2025-09-30 | $21 |
| 2025-06-30 | $20 |
| 2025-03-31 | $22 |
| 2024-12-31 | $25 |
| 2024-09-30 | $22 |
| 2024-06-30 | $23 |
| 2024-03-31 | $25 |
| 2023-12-31 | $28 |
| 2023-09-30 | $25 |
| 2023-06-30 | $29 |
| 2023-03-31 | $30 |
| 2022-12-31 | $28 |
| 2022-09-30 | $27 |
| 2022-06-30 | $29 |
| 2022-03-31 | $29 |
| 2021-12-31 | $33 |
| 2021-09-30 | $30 |
| 2021-06-30 | $29 |
| 2021-03-31 | $27 |
| 2020-12-31 | $31 |
| 2020-09-30 | $24 |
| 2020-06-30 | $23 |
| 2020-03-31 | $24 |
| 2019-12-31 | $31 |
| 2019-09-30 | $27 |
| 2019-06-30 | $30 |
| 2019-03-31 | $28 |
| 2018-12-31 | $34 |
| 2018-09-30 | $29 |
| 2018-06-30 | $32 |
| 2018-03-31 | $27 |
| 2017-12-31 | $22 |
| 2017-09-30 | $19 |
| 2017-06-30 | $19 |
| 2017-03-31 | $18 |
| 2016-12-31 | $26 |
| 2016-09-30 | $25 |
| 2016-06-30 | $26 |
| 2016-03-31 | $27 |
| 2015-12-31 | $28 |
| 2015-09-30 | $26 |
| 2015-06-30 | $29 |
| 2015-03-31 | $26 |
| 2014-12-31 | $30 |
| 2014-09-30 | $25 |
| 2014-06-30 | $27 |
| 2014-03-31 | $26 |
| 2013-12-31 | $28 |
| 2013-09-30 | $25 |
| 2013-06-30 | $26 |
| 2013-03-31 | $26 |
| 2012-12-31 | $28 |
| 2012-09-30 | $26 |
| 2012-06-30 | $28 |
| 2012-03-31 | $28 |
| 2011-12-31 | $29 |
| 2011-09-30 | $26 |
| 2011-06-30 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |